컨퍼런스 커버리지 | 학술센터 | 킴스온라인

주요메뉴 바로가기
본문 바로가기
하단메뉴 바로가기

최근 해외학술대회의 주요 발표내용을 제공합니다.

컨퍼런스 커버리지

European Society of Human Reproduction and Embryology (ESHRE) 41st Annual Meeting

29 June - 02 July, 2025, France

Periconceptional GLP-1RA exposure safety varies on indication for use

2025-10-01

Exposure to glucagon-like peptide 1 receptor agonists (GLP-1RAs) during pregnancy poses a modest increase in the risk of preterm birth in the context of diabetes treatment, but there is no evidence of increased obstetric complications when the drugs are exclusively used for weight management, according to new research.
Older paternal age a risk factor for poor reproductive outcomes after ICSI

2025-10-01

Paternal age appears to independently factor in the success of intracytoplasmic sperm injection (ICSI), with sperm from men over 45 years of age being associated with increased risk of miscarriage and lower live birth rates, according to a retrospective study.
Does UPF intake affect semen quality in men?

2025-10-01

Consumption of ultra-processed food (UPF) does not appear to influence semen quality parameters among men attending a fertility clinic, suggests a study presented at ESHRE 2025.
Mental health assessment essential after pregnancy loss

2025-10-01

Pregnancy loss is devastating to any couple, and such an experience may result in depression, stress, and anxiety, particularly among women.
Microplastics present in human reproductive fluids

2025-10-01

Data presented at ESHRE 2025 indicate the presence of microplastics (MPs) in follicular and seminal fluids, underscoring concerns about their potential impact on reproductive health.
Follitropin delta as good as follitropin alfa for ovarian stimulation in IVF

2025-10-01

Follitropin delta 15 µg/day and follitropin alfa 225 IU/day as starting doses yielded similar ovarian responses in women undergoing ovarian stimulation for in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), according to the ADAPT-1 trial presented at ESHRE 2025.
Add-on clomiphene citrate benefits women with anovulation, PCOS

2025-10-01

Adding clomiphene citrate (CC) to letrozole improves ovulation as opposed to letrozole alone in women with polycystic ovarian syndrome (PCOS) or anovulatory infertility, findings from a study suggest.

1

최근 본 콘텐츠

최근 본 콘텐츠가 없습니다

TOP

주식회사 킴스

주식회사 킴스 | 광고/제휴문의 | 이용약관 | 개인정보처리방침 | 법적 책임의 한계 | 서비스 전체보기

서울특별시 강남구 테헤란로 8길 33 청원빌딩 1층 (주)킴스
개인정보관리책임자 : 최동섭 사업자등록번호 : 214-81-75415 통신판매업신고 : 강남-5166호 대표이사 : 마사키 타카하타
고객센터 : 1544-2930 (10:00~17:00, 주말/공휴일 제외) 팩스 : 02-3019-9380 e-mail : webmaster@kims.co.kr

Copyright © 1987-2025 KIMS Co., Ltd All Rights Reserved

KIMS 페이스북

KIMS 유튜브